Trials / Unknown
UnknownNCT02604732
Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair
Randomized Controlled Trial on Pre-operative Withdrawal Versus no Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- National University Hospital, Singapore · Academic / Other
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery.
Detailed description
This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery. Simple randomization will be performed and allocation is via closed envelope method. The surgeon will be blinded regarding the usage of Aspirin. The primary outcome is the incidence of post-operative hematoma formation within the first 24 hours after surgery. The secondary outcomes are the incidence of post-operative seroma formation within 24 hours, the incidence of post-operative hematoma requiring intervention (including blood transfusion, percutaneous drainage and surgical hemostasis) within 30 days, pain at regular intervals and the incidence of other post-operative complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Laparoscopic inguinal hernia repair with perioperative Aspirin | Patients undergoing laparoscopic inguinal hernia repair will continue on Aspirin perioperatively |
| PROCEDURE | Laparoscopic inguinal hernia repair without perioperative Aspirin | Patients undergoing laparoscopic inguinal hernia repair will stop Aspirin 5-7 days before the surgery |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2024-02-29
- Completion
- 2024-05-31
- First posted
- 2015-11-13
- Last updated
- 2023-04-19
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT02604732. Inclusion in this directory is not an endorsement.